SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : International Nursing Services Inc, old (NURS) new (MDIX) -- Ignore unavailable to you. Want to Upgrade?


To: Robert E. Winston who wrote (2453)1/20/1999 9:03:00 AM
From: Graham Marshman  Read Replies (1) | Respond to of 2911
 
Robert,
You're right on with what I was thinking. The hardest job for one of these small software companies is making sales - no substitute for feet on the street. Cymedix appears to be in better shape on this since they'll do a few large sales rather than thousands of individual ones. First sale is the hardest and if Wellpoint is it that's great.

The deployment tasks, training, support etc are relatively easy to address with minimum expense. The other bright part is that these costs are so minimal, cash flow can and often does come fast.
Graham



To: Robert E. Winston who wrote (2453)1/20/1999 9:51:00 AM
From: Mike Moran  Respond to of 2911
 
<< Another possibility is that WellPoint, which no doubt has a substantial IS staff of it's own, will do the training and support.>>

Remember this is still a pilot. Wellpoint needs to be impressed. I heard at an important conference last week, as did many other companies that would love Wellpoint's business, that MDIX may be too resource poor to handle a big client. That is news not hype. I believe this company may have a bright future. I own my own small piece.

Please do not come into this folder and count phantom $24 million. Call the Cymedix internet division and ask. Call Wellpoint Pharmacy and ask. There are phone numbers on their joint news release.